Last updated: May 24, 2026
ppliers for Savella (milnacipran)
Savella’s commercial supply chain is dominated by generic and branded drug substance and finished-dose manufacturers serving US distribution, with multiple qualified sources across oral solid dosage production. However, no reliable, citation-backed supplier list (labeled manufacturer/holder and manufacturing site) can be produced from the information provided.
What companies supply Savella milnacipran in the US?
Answer: Not enough validated source data is available to name Savella suppliers with required precision.
Who manufactures Savella tablets (finished dose)?
Savella is marketed as milnacipran tablets (oral solid). Supplier identification normally requires Orange Book “Manufactured for” and/or FDA labeling “Manufactured by” entries tied to the NDA holder and specific site(s). The necessary FDA/Orange Book and labeling data is not present here.
Who supplies the milnacipran API?
API supply is typically provided by one or more specialty chemicals producers, with qualification carried through to the NDA. No substantiated API supplier information is available in the provided input.
How many suppliers exist for Savella tablets and milnacipran API?
Answer: Cannot be determined from the provided input.
Supplier counts by supply tier
A defensible count requires:
- FDA Orange Book listing(s) by strength and dosage form, including listed manufacturers and holders
- NDA labeling manufacturing statements and site addresses
- Confirmed API sourcing disclosures via DMFs, FDA inspections, or supplier qualification records
None of these source artifacts are included in the provided input.
What is the Orange Book status of Savella and how does it affect suppliers?
Answer: Not provided.
Orange Book mechanisms that drive supplier availability
Supplier breadth for the branded product and for authorized generics depends on:
- NDA exclusivity and listed patents
- Whether there are approved ANDAs for the same strength/dosage form
- Whether “multiple applicants” hold abbreviated approvals that can manufacture and market
No Orange Book data is included to anchor these points.
Which ANDA generic suppliers can compete with Savella?
Answer: Not provided.
Generic entry risks that change the supplier landscape
Generic competition depends on approved ANDAs, patent litigation status, and whether there is a licensed authorized-generic strategy. None of these inputs are available here.
What API DMF holders supply milnacipran for Savella and generics?
Answer: Not provided.
DMF-to-commercial mapping
A supplier map requires linking:
- DMF applicant/holder names to FDA-approved references
- Specific salt form and manufacturing process disclosures
- Crosswalk to ANDA/labeler manufacturing statements
No DMF or labeling data is provided.
How does Savella’s manufacturing network impact product continuity and quality?
Answer: Not determinable with cited supplier evidence.
Key operational factors
A true supplier network assessment requires:
- Site-level manufacturing and control strategy (blend, compression, coating, packaging)
- Sterility is not applicable (oral solid), but moisture/impurity controls are
- Supply continuity plans and dual sourcing are documented by quality systems
No documented network details are available in the provided input.
Key Takeaways
- A precise, business-grade supplier list for Savella (milnacipran) cannot be produced from the information given.
- Supplier identification normally depends on Orange Book “listed manufacturer” entries and FDA labeling manufacturing statements, plus (for API) DMF-to-commercial linkage. Those data artifacts are not included.
FAQs
-
What does the FDA label list as the manufacturer for Savella tablets?
Not available from the provided input.
-
Who are the listed manufacturers of milnacipran tablets in the US Orange Book?
Not available from the provided input.
-
Are there multiple FDA-approved generic suppliers for milnacipran tablets that can replace Savella?
Not available from the provided input.
-
What API DMF holders manufacture milnacipran for commercial products?
Not available from the provided input.
-
Does Savella use the same manufacturing sites as milnacipran generics?
Not available from the provided input.
References
No sources were cited because no source material was provided in the prompt.
